Alexander S Perlmutter1,2, Myrela Bauman1,3, Shivani Mantha1, Luis E Segura1, Lilian Ghandour4, Silvia S Martins1. 1. Department of Epidemiology, Columbia University Mailman School of Public Health, 722 West 168th St. Rm. 509, New York, NY 10032. 2. Centre de Recherche d'Épidémiologie et Statistique Paris Sorbonne-Cité, Université Paris Descartes, Hôpital Hôtel-Dieu, 1 Place du Parvis-Notre Dame, Paris, France 75004. 3. School of International and Public Affairs, Columbia University, 420 W 118th St #1410, New York, NY 10027. 4. Department of Epidemiology & Population Health, Faculty of Health Sciences (FHS), American University of Beirut, Beirut - Lebanon 1107-2020, P.O.Box 11-0236.
Abstract
PURPOSE OF REVIEW: This paper reviews the most recent epidemiological evidence on adolescent NMPD use. Particular attention is given to prevention, assessment and diagnosis of disorder, and treatment. RECENT FINDINGS: While international in scope, global evidence is only available for NMPD use, morbidity and mortality estimates. Prevention strategies, assessment and treatment are U.S.-centric. The literature on prevention strategies lacks high-quality evidence. Assessment, diagnosis and treatment of NMPD use disorder have more robust evidence bases. Despite this, screening for NMPD (and other drug) use disorders is infrequent and insensitive, leading to incomplete treatment provision. Treatments are shown to be safe and effective, but disparities in provision prevent wide-scale amelioration of the adolescent NMPD use problem. SUMMARY: Mental health care professionals and primary care physicians with adolescent patient populations should become involved in preventative strategies mentioned in this review. Additionally, higher screening rates will lead to less downstream problems related to NMPD use.
PURPOSE OF REVIEW: This paper reviews the most recent epidemiological evidence on adolescent NMPD use. Particular attention is given to prevention, assessment and diagnosis of disorder, and treatment. RECENT FINDINGS: While international in scope, global evidence is only available for NMPD use, morbidity and mortality estimates. Prevention strategies, assessment and treatment are U.S.-centric. The literature on prevention strategies lacks high-quality evidence. Assessment, diagnosis and treatment of NMPD use disorder have more robust evidence bases. Despite this, screening for NMPD (and other drug) use disorders is infrequent and insensitive, leading to incomplete treatment provision. Treatments are shown to be safe and effective, but disparities in provision prevent wide-scale amelioration of the adolescent NMPD use problem. SUMMARY: Mental health care professionals and primary care physicians with adolescent patient populations should become involved in preventative strategies mentioned in this review. Additionally, higher screening rates will lead to less downstream problems related to NMPD use.
Entities:
Keywords:
adolescent; diagnosis; nonmedical prescription drug use; prevention; review; treatment
Authors: Anthony Spirito; Peter M Monti; Nancy P Barnett; Suzanne M Colby; Holly Sindelar; Damaris J Rohsenow; William Lewander; Mark Myers Journal: J Pediatr Date: 2004-09 Impact factor: 4.406
Authors: Scott E Hadland; J Frank Wharam; Mark A Schuster; Fang Zhang; Jeffrey H Samet; Marc R Larochelle Journal: JAMA Pediatr Date: 2017-08-01 Impact factor: 16.193
Authors: Scott P Novak; Anders Håkansson; Jose Martinez-Raga; Jens Reimer; Karol Krotki; Sajan Varughese Journal: BMC Psychiatry Date: 2016-08-04 Impact factor: 3.630
Authors: Alexander S Perlmutter; Ariadne E Rivera-Aguirre; Pia M Mauro; Alvaro Castillo-Carniglia; Nicolás Rodriguez; Nora Cadenas; Magdalena Cerdá; Silvia S Martins Journal: Drug Alcohol Depend Date: 2019-10-04 Impact factor: 4.492
Authors: Henry N Young; Farah Pathan; Jaxk H Reeves; Kristen N Knight; FuNing Chen; Elizabeth D Cox; Megan A Moreno Journal: J Am Coll Health Date: 2019-10-29